These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20306255)

  • 1. Natural killer cell-based immunotherapy for acute myeloid leukemia.
    Xu J; Niu T
    J Hematol Oncol; 2020 Dec; 13(1):167. PubMed ID: 33287858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
    Smits EL; Lee C; Hardwick N; Brooks S; Van Tendeloo VF; Orchard K; Guinn BA
    Cancer Immunol Immunother; 2011 Jun; 60(6):757-69. PubMed ID: 21519825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities for immunotherapy in childhood acute myeloid leukemia.
    Lamble AJ; Tasian SK
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):218-225. PubMed ID: 31808843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-based therapeutics for pediatric cancer.
    Capitini CM; Mackall CL; Wayne AS
    Expert Opin Biol Ther; 2010 Feb; 10(2):163-78. PubMed ID: 19947897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
    Liu Y; Bewersdorf JP; Stahl M; Zeidan AM
    Blood Rev; 2019 Mar; 34():67-83. PubMed ID: 30553527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in AML: a brief review on emerging strategies.
    Moeinafshar A; Hemmati S; Rezaei N
    Clin Transl Oncol; 2021 Dec; 23(12):2431-2447. PubMed ID: 34160771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of AML.
    Alatrash G; Molldrem JJ
    Cancer Treat Res; 2010; 145():237-55. PubMed ID: 20306255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
    Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in acute myeloid leukemia.
    Arpinati M; Curti A
    Immunotherapy; 2014; 6(1):95-106. PubMed ID: 24341888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia.
    Agrawal V; Gbolahan OB; Stahl M; Zeidan AM; Zaid MA; Farag SS; Konig H
    Curr Cancer Drug Targets; 2020; 20(7):473-489. PubMed ID: 32357813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.
    Ando T; Mitani N; Matsunaga K; Nakazora T; Gondo T; Yujiri T; Tanizawa Y
    Tohoku J Exp Med; 2010 Feb; 220(2):121-6. PubMed ID: 20139663
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.